As long as the immune system is efficient, the T-Cells will find all the malfunctioning cells, and destroy them. Otherwise, some cells will survive and become tumors.
The CBCD sees immunotherapy as an attempt to compensate for a weak immune system. That is, to entice the weak immune system to find malfunctioning cells, specifically those with a high concentration of latent viruses.
However, by eradicating latent viral infections, and therefore avoiding Microcompetition from the start, patients will not develop cancer and will not need cancer therapies.
The Center recommends that health professionals turn to Dr. Polansky’s book, “Microcompetition with Foreign DNA and the Origin of Chronic Disease” for a better understanding of the risks posed by latent viruses, and how helping the immune system to eradicate them may improve cancer patient outcomes.
To learn more about Dr. Hanan Polansky’s research and the Theory of Microcompetition with Foreign DNA, visit: http://www.cbcd.net.
(1) Science journal’s top 10 breakthroughs, 2013. Published on December 26, 2013.
(2) Science magazine picks top breakthroughs of 2013. Published on January 5, 2014.
Copyright©2012 Vocus, Inc.
All rights reserved